<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20241027063509N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2025-03-29</date_registration>
      <primary_sponsor>Mashhad University of Medical Sciences</primary_sponsor>
      <public_title>Investigating the Effects of Dual-Tasking with Virtual Reality on Stroke Patients</public_title>
      <acronym></acronym>
      <scientific_title>Evaluation of the effects of adding virtual reality to dual-task gait training on balance, gait quality and quality of life in stroke survivors: a randomized clinical trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2025-04-19</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>30</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/80221</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Triple blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: To randomly assign patients to study groups, a random block design will be employed. Five blocks of six will be generated randomly using the website [Sealed Envelope](https://www.sealedenvelope.com/). For example, the generated sequences may look as follows: [AAABSB], [ABABAB], [GBAAAB], [ABBAAI], [BBAA], [BABABA], Blinding description: The physiotherapist responsible for outcome assessment is blinded to group assignments. Patients are randomly assigned to control or intervention groups; therefore, the group allocator is also blinded to the treatment groups. Similarly, the statistician analyzing the data is also blinded to group assignments, with the data provided to him in a coded format.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Cerebrovascular accident.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: The intervention for both groups consists of 15 sessions conducted over 5 consecutive weeks, with a frequency of three sessions per week.The intervention group receives electrotherapy and standard exercises for 40 minutes per session, similar to the control group. The control group performs strengthening exercises for the shoulder and elbow extensors, hip extensors and abductors, and knee extensors and flexors on a treatment table. The primary difference between the groups lies in the rehabilitation activities focused on walking. In both groups, each session includes:- 20 minutes of electrotherapy using Functional Electrical Stimulation (FES)- 20 minutes of standard therapeutic exercises for stroke patients- 20 minutes of walking exercises on a treadmill. During treadmill walking, a harness is used to protect patients from the risk of falling, although it does not provide any weight suspension. The treadmill speed starts at 0.8 kilometers per hour and is increased by 0.1 to 0.2 kilometers per hour in each session, depending on the patient's condition, until the maximum tolerable speed is reached. Additionally, during treadmill walking, patients in both groups are assigned cognitive tasks by the therapist, focusing on attention spans and executive functions. In the intervention group, patients begin walking in a simulated environment resembling a street, shopping center, etc., using virtual reality head mounted display that provide a fully immersive experience. Intervention 2: Control group: The intervention for both groups consists of 15 sessions conducted over 5 consecutive weeks, with a frequency of three sessions per week. Each session lasts 60 minutes. The intervention group receives electrotherapy and standard exercises for 40 minutes per session, similar to the control group. The control group performs strengthening exercises for the shoulder and elbow extensors, hip extensors and abductors, and knee extensors and flexors on a treatment table. The primary difference between the groups lies in the rehabilitation activities focused on walking. In both groups, each session includes:- 20 minutes of electrotherapy using Functional Electrical Stimulation (FES)- 20 minutes of standard therapeutic exercises for stroke patients- 20 minutes of walking exercises on a treadmill. During treadmill walking, a harness is used to protect patients from the risk of falling, although it does not provide any weight suspension. The treadmill speed starts at 0.8 kilometers per hour and is increased by 0.1 to 0.2 kilometers per hour in each session, depending on the patient's condition, until the maximum tolerable speed is reached. Additionally, during treadmill walking, patients in both groups are assigned cognitive tasks by the therapist, focusing on attention spans and executive functions.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is The data collection is still ongoing.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Hossein Negahban</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>School of Paramedical Sciences and Rehabilitation, University Campus, Azadi Square</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9177948964</zip>
        <telephone>+98 51 3884 6713</telephone>
        <email>honegahban@yahoo.com</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mohammad Javad Dolatabadian</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>No. 9, Ayatollah Ebadi 56 Ave.</address>
        <city>Mashhad</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>9193963677</zip>
        <telephone>+98 51 3731 8172</telephone>
        <email>dolatabadianmj4012@mums.ac.ir</email>
        <affiliation>Mashhad University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Hemiplegia resulting from a single stroke
Sub-acute and chronic phase
Being able to walk 10m without or with single point stick
Score greater than 24 in the mini-mental state examination</inclusion_criteria>
      <agemin>40 years</agemin>
      <agemax>80 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>patients with speech disorders following stroke
patients with hemianopia or visual eye field disorders
patients with vestibular disorders
patients with auditory defect
patients with major cardiac problems or uncontrolled hypertension
patients with any other neurological disorder
patients with orthopedic issues and other factors that impact walking, like osteoarthritis or undergoing a complete hip joint replacement</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>I63.9</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Cerebral infarction, unspecified</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Devices</i_code>
      <i_code>Treatment - Devices</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: The intervention for both groups consists of 15 sessions conducted over 5 consecutive weeks, with a frequency of three sessions per week.The intervention group receives electrotherapy and standard exercises for 40 minutes per session, similar to the control group. The control group performs strengthening exercises for the shoulder and elbow extensors, hip extensors and abductors, and knee extensors and flexors on a treatment table. The primary difference between the groups lies in the rehabilitation activities focused on walking. In both groups, each session includes:- 20 minutes of electrotherapy using Functional Electrical Stimulation (FES)- 20 minutes of standard therapeutic exercises for stroke patients- 20 minutes of walking exercises on a treadmill. During treadmill walking, a harness is used to protect patients from the risk of falling, although it does not provide any weight suspension. The treadmill speed starts at 0.8 kilometers per hour and is increased by 0.1 to 0.2 kilometers per hour in each session, depending on the patient's condition, until the maximum tolerable speed is reached. Additionally, during treadmill walking, patients in both groups are assigned cognitive tasks by the therapist, focusing on attention spans and executive functions. In the intervention group, patients begin walking in a simulated environment resembling a street, shopping center, etc., using virtual reality head mounted display that provide a fully immersive experience.</i_keyword>
      <i_keyword>Control group: The intervention for both groups consists of 15 sessions conducted over 5 consecutive weeks, with a frequency of three sessions per week. Each session lasts 60 minutes. The intervention group receives electrotherapy and standard exercises for 40 minutes per session, similar to the control group. The control group performs strengthening exercises for the shoulder and elbow extensors, hip extensors and abductors, and knee extensors and flexors on a treatment table. The primary difference between the groups lies in the rehabilitation activities focused on walking. In both groups, each session includes:- 20 minutes of electrotherapy using Functional Electrical Stimulation (FES)- 20 minutes of standard therapeutic exercises for stroke patients- 20 minutes of walking exercises on a treadmill. During treadmill walking, a harness is used to protect patients from the risk of falling, although it does not provide any weight suspension. The treadmill speed starts at 0.8 kilometers per hour and is increased by 0.1 to 0.2 kilometers per hour in each session, depending on the patient's condition, until the maximum tolerable speed is reached. Additionally, during treadmill walking, patients in both groups are assigned cognitive tasks by the therapist, focusing on attention spans and executive functions.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Balance score in Berg Balance Scale. Timepoint: Before intervention and immediately after 15 sessions of intervention. Method of measurement: To measure effect of the intervention on balance, the Berg Balance Scale is used: The Functional Balance Assessment, developed by Katherine Berg, is a performance-based test designed to evaluate balance. The assessment takes approximately 10 to 20 minutes to complete and consists of 14 tasks. Each task is scored on a scale from 0 to 4, with 0 indicating the lowest level of performance and 4 the highest. A total score of 20 or less suggests that the patient will require a wheelchair. Scores between 21 and 40 indicate that the patient will need assistance with walking. Patients scoring above 40 are considered capable of walking independently.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Dynamic balance score in Modified Four Square Step Test. Timepoint: Before intervention and immediately after 15 sessions of intervention. Method of measurement: The Modified Four Square Step Test is a performance-based assessment designed to evaluate dynamic balance. To conduct this test, a one-square-meter area is marked on the ground and divided into four equal squares using tape, numbered 1 to 4 in a clockwise direction. The test subject stands in square 1 facing square 2 and first completes a full clockwise rotation around square 1, returning to square 1. This is followed by a full counterclockwise rotation, again returning to square 1. The therapist records the time from the first foot contact in the initial step to the last foot contact in the final step.</sec_outcome>
      <sec_outcome>Balance score in Activity-Specific Balance Confidence questionnaire. Timepoint: Before intervention and immediately after 15 sessions of intervention. Method of measurement: The Activity-Based Balance Confidence Questionnaire is a patient-centered instrument designed to measure an individual's confidence in their balance during daily activities, without experiencing unsteadiness or fear of falling. This questionnaire consists of 16 items. The participant is required to express their level of confidence in their balance for each of these 16 activities as a percentage, where 0% indicates no confidence and 100% indicates complete confidence.</sec_outcome>
      <sec_outcome>Mobility score in Timed up and go test. Timepoint: Before intervention and immediately after 15 sessions of intervention. Method of measurement: The test aims to evaluate fall risk and monitor balance progression during various activities, including sitting, standing, and walking. The procedure requires the patient to wear their regular shoes and, if needed, use a walking aid. The patient starts in a seated position and, upon the therapist’s instruction, stands up. The patient then walks a distance of 3 meters, turns around, walks back to the chair, and sits down. The test duration is recorded from the moment the patient begins to rise until they are fully seated.</sec_outcome>
      <sec_outcome>Walking speed in 10 Meters walk test. Timepoint: Before intervention and immediately after 15 sessions of intervention. Method of measurement: This test is designed to measure walking speed over a short distance and can be conducted in two forms: at maximum speed or at the patient's normal speed. To perform the test, a stopwatch and a clear, flat, unobstructed 10-meter pathway are required, with markers placed at 2 meters and 8 meters. The patient stands at the starting point and begins walking upon the therapist's command, continuing to the endpoint at either maximum or normal speed, depending on the test type. The therapist records the time taken to traverse the distance between the 2-meter and 8-meter markers, which is then used to calculate walking speed.</sec_outcome>
      <sec_outcome>Distance traveled in "six-Minutes walk test". Timepoint: Before intervention and immediately after 15 sessions of intervention. Method of measurement: This test assesses aerobic capacity and endurance by measuring the distance covered in 6 minutes. The distance serves as an outcome measure to compare changes in functional capacity over time.</sec_outcome>
      <sec_outcome>Quality of life score in Stroke Specific Quality of Life Scale questionnaire. Timepoint: Before intervention and immediately after 15 sessions of intervention. Method of measurement: The Stroke-Specific Quality of Life Scale (SS-QOL) is a patient-centered assessment tool specifically designed to evaluate the quality of life of individuals who have experienced a stroke. Patients are instructed to respond to each question based on their experiences over the past week. This self-report scale includes 49 items across 12 domains: participation (6 items), energy (3 items), upper extremity function (5 items), self-care (5 items), social roles (5 items), family roles (3 items), goals (3 items), language (5 items), thinking (3 items), and personality (3 items). The items are rated on a 5-point scale, resulting in a minimum score of 49 and a maximum score of 245.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Mashhad University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2024-06-29</approval_date>
        <contact_name>Ethics committee of Mashhad University of Medical Sciences</contact_name>
        <contact_address>School of Paramedical Sciences and Rehabilitation,  University Campus, Azadi Square Mashhad Razavi Khorasan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
